Regarding "A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency"

被引：2

作者：

Lee, Byung-Boong ^{[1
]}

机构：

[1] Georgetown Univ, Sch Med, Dept Surg, Washington, DC 20057 USA

来源：

JOURNAL OF VASCULAR SURGERY | 2010年 / 52卷 / 02期

关键词：

MALFORMATIONS;

D O I：

10.1016/j.jvs.2010.03.030

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：533 / 533

页数：1

共 50 条

[31] Olanzapine in the treatment of depression with psychotic features: A prospective open-label study
Adli, Mazda
Wiethoff, Katja
Baethge, Christopher
Pfennig, Andrea
Stamm, Thomas
Bauer, Michael
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (03) : 202 - 209
[32] Infliximab for severe, treatment resistant psoriasis: a prospective, open-label study
Smith, CH
Jackson, K
Bashir, S
Chew, A
Powell, A
Perez, A
Wain, M
Barker, JNWN
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
[33] Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study
Hwang, Angelina S.
Kechter, Jacob A.
Li, Xing
Hughes, Alysia
Severson, Kevin J.
Boudreaux, Blake
Bhullar, Puneet
Nassir, Shams
Yousif, Miranda
Zhang, Nan
Butterfield, Richard J.
Nelson, Steven
Xing, Xianying
Tsoi, Lam C.
Zunich, Samantha
Sekulic, Aleksandar
Pittelkow, Mark
Gudjonsson, Johann E.
Mangold, Aaron
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (09)
[34] Zonisamide in the Treatment of Bulimia Nervosa: An Open-Label, Pilot, Prospective Study
Guerdjikova, Anna I.
Blom, Thomas J.
Martens, Brian E.
Keck, Paul E., Jr.
McElroy, Susan L.
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2013, 46 (07) : 747 - 750
[35] An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Ahmed, Fayyaz
Gaul, Charly
Garcia-Monco, Juan Carlos
Sommer, Katherine
Martelletti, Paolo
Afanador, Lauriaselle
Franznick, Dana
Asmus, Peter
Becker, Veit
Boeger, Andrea
Buschmann, Dirk
Dulcius, Andrea
Ebke, Markus
Engelmann, Christoph
Eser, Anna-Katharina
Foerster, Heike
Freitag, Frank
Gaul, Charly
Gendolla, Astrid
Gerlach, Klaus
Gessler, Martin
Goebel, Hartmut
Guenther, Olaf
Halbgewachs, Frank
Hamacher, Juergen
Haendel, Dorothea
Haslbeck, Matthias
Heinicke, Volker
Hellwig, Bernhard
Herbst, Heinz Peter
Hesselbarth, Sabine
Jaeger, Hanno
Jansen, Jan-Peter
Jost, Wolfgang
Kaube, Holger
Kirchhoefer, Ulrike
Kiszka, Michael
Klimpel, Lothar
Koehler, Ulrike
Kollewe, Katja
Kornhuber, Anselm
Krause, Michaela
Krome, Kathrin
Kukowski, Borries
Kupsch, Andreas
Leger, Roland
Lux, Eberhard Albert
Mueller, Gabriele
Mueller-Schwefe, Gerhard
Nautscher-Timmermann, Stephan
JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
[36] An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Fayyaz Ahmed
Charly Gaul
Juan Carlos García-Moncó
Katherine Sommer
Paolo Martelletti
The Journal of Headache and Pain, 2019, 20
[37] Pioglitazone in acromegaly - an open-label, prospective study
Kim, David D. W.
Goh, Jovina
Panossian, Zaven
Gamble, Greg
Holdaway, Ian
Grey, Andrew
CLINICAL ENDOCRINOLOGY, 2012, 77 (04) : 575 - 578
[38] Tolerability of tiagabine: a prospective open-label study
Bauer, J
Bergmann, A
Reuber, M
Stodieck, SRG
Genton, P
EPILEPTIC DISORDERS, 2002, 4 (04) : 257 - 260
[39] Injection Botulinum Toxin A in Treatment of Resistant Chronic Low Back Pain: A Prospective Open-Label Study
Sahoo, Jagannatha
Jena, Debasish
Viswanath, Amrutha
Barman, Apurba
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
[40] Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study
Syal, Gaurav
Mishkin, Daniel S.
Banty, Andrea
Lee, Susie
Fontelera, Norma
Hampton, Melissa
Ziring, David
Fleshner, Phillip R.
Melmed, Gil Y.
INFLAMMATORY BOWEL DISEASES, 2023, 30 (10) : 1907 - 1910

← 1 2 3 4 5 →